抗弓形虫药物应用现状与研究进展  

Current situation and research progress of anti-Toxoplasma drugs

作　　者：张吉丽[1] 司鸿飞 李冰[1] 周绪正[1] 张继瑜[1] ZHANG Ji-li;SI Hong-fei;LI Bing;ZHOU Xu-zheng;ZHANG Ji-yu(Key Laboratory of Veterinary Pharmaceutical Development,Ministry of A griculture/Lanzhou Institute of Husbandry and Pharmaceutical Sciences,Chinese Academy of Agricultural Sciences,Lanzhou 730050,China)

机构地区：[1]中国农业科学院兰州畜牧与兽药研究所农业部兽药创制重点实验室

出　　处：《中国兽医科学》2019年第8期1054-1060,共7页Chinese Veterinary Science

基　　金：国家科技支撑计划项目(2015BAD11B01);国家现代农业产业技术体系专项(CARS-37)

摘　　要：动物弓形虫病的防控对人类身体健康、畜牧业健康发展和公共卫生安全具有重要保障作用。近年来抗弓形虫药物研发工作进展较快,本文综述了抗弓形虫药物治疗现状、存在的问题、最新进展,预测了今后的研发方向。Prevention and control of animal toxoplasmosis plays an important role in ensuring human health,healthy development of animal husbandry and the safety of public health.Recent years,the research and development of anti-Toxoplasma drugs have made rapid progress,this article summarizes the current situation,existing problems and latest progress of anti-Toxoplasma drugs, and predicts the direction of future research and development.

关 键 词：弓形虫病 传统治疗 中草药 联合用药 药物靶标 

分 类 号：S852.723[农业科学—基础兽医学]